Phase II study of dasatinib in patients with previously treated malignant mesothelioma (Cancer and leukemia group B 30601): A brief report

Arkadiusz Z. Dudek, Herbert Pang, Robert A. Kratzke, Gregory A. Otterson, Lydia Hodgson, Everett E. Vokes, Hedy L. Kindler

Research output: Contribution to journal › Article › peer-review

55 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of dasatinib in patients with previously treated malignant mesothelioma (Cancer and leukemia group B 30601): A brief report'. Together they form a unique fingerprint.

Medicine & Life Sciences